Skip to main content
SpringerLink
Log in

Amiodarone/dabigatran-etexilate

Nephropathy and increase the plasma concentration of dabigatran: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Alsamarrai A, et al. Idarucizumab for the treatment of dabigatran-related nephropathy. Clinical Kidney Journal 14: 710-711, No. 2, Feb 2021. Available from: URL: http://ckj.oxfordjournals.org/

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Amiodarone/dabigatran-etexilate. Reactions Weekly 1910, 27 (2022). https://doi.org/10.1007/s40278-022-16862-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-16862-z

Search

Navigation